3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Other neoplasm
1
Conditions
Precancerous Conditions
6
Thrombocythemia, Essential
2
Primary Myelofibrosis
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Hodgkin Disease
2
Waldenstrom Macroglobulinemia
1
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Sezary Syndrome
1
Recurrence
1
Rectal Malignant Neoplasms
1
Preleukemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms by Histologic Type
1
Neoplasms
1
Mycosis Fungoides
1
Menstruation Disturbances
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Mantle-Cell
1
Interventions
Robotic Surgical Procedures
1
Hysterectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Prolapse
×
Other neoplasm
×
30 days
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled